Rho-Kinase Mediates Hyperglycemia-Induced Plasminogen Activator Inhibitor-1 Expression in Vascular Endothelial Cells

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation

• Publication date

  2005-06-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.105.534024PMID 15956119PMCID PMC2633592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• L-type Voltage-Gated Ca2+ Channels Modulate Expression of Smooth Muscle Differentiation Marker Genes via a Rho Kinase/Myocardin/SRF–Dependent Mechanism

  2004cited by this paper
• Selective Inhibition of Protein Kinase Cβ2 Prevents Acute Effects of High Glucose on Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells

  2004cited by this paper
• Channeling to myocardin.

  2004cited by this paper
• DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.

  2004cited by this paper
• Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones

  2004cited by this paper
• High Glucose-Induced Upregulation of Osteopontin Is Mediated via Rho/Rho Kinase Pathway in Cultured Rat Aortic Smooth Muscle Cells

  2004cited by this paper
• The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis.

  2004cited by this paper
• Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment.

  2003cited by this paper
• Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease.

  2003cited by this paper
• High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells: Role of Protein Kinase C and Reactive Oxygen Species

  2003cited by this paper
• Reactive oxygen species-regulated signaling pathways in diabetic nephropathy.

  2003cited by this paper
• The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor.

  2003cited by this paper
• Important Role of Rho-kinase in the Pathogenesis of Cardiovascular Inflammation and Remodeling Induced by Long-Term Blockade of Nitric Oxide Synthesis in Rats

  2002cited by this paper
• Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr850 induces its dissociation from myosin

  2002cited by this paper
• 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy

  2002cited by this paper
• Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

  2002cited by this paper
• Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase

  2002cited by this paper
• Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina

  2002cited by this paper
• Protein Kinase C-α Signals Rho-Guanine Nucleotide Dissociation Inhibitor Phosphorylation and Rho Activation and Regulates the Endothelial Cell Barrier Function*

  2001cited by this paper
• Critical Role of Rho-Kinase and MEK/ERK Pathways for Angiotensin II-Induced Plasminogen Activator Inhibitor Type-1 Gene Expression

  2001cited by this paper
• Mechanosensitive Transcription Factors Involved in Endothelin B Receptor Expression*

  2001cited by this paper
• Possible Involvement of Rho-Kinase in the Pathogenesis of Hypertension in Humans

  2001cited by this paper
• Permissive role of protein kinase Cα but not protein kinase Cδ in sphingosine 1‐phosphate‐induced RhoA activation in C2C12 myoblasts

  2000cited by this paper
• Rho-Kinase Is Involved in Macrophage-Mediated Formation of Coronary Vascular Lesions in Pigs In Vivo

  2000cited by this paper
• Permissive role of protein kinase C alpha but not protein kinase C delta in sphingosine 1-phosphate-induced Rho A activation in C2C12 myoblasts.

  2000cited by this paper
• Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance

  2000cited by this paper
• Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm.

  2000cited by this paper
• Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.

  2000cited by this paper
• High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells.

  2000cited by this paper
• Regulation and functions of Rho-associated kinase.

  2000cited by this paper
• Inhibitory Phosphorylation Site for Rho-associated Kinase on Smooth Muscle Myosin Phosphatase*

  1999cited by this paper
• Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

  1999cited by this paper
• Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox.

  1999cited by this paper
• Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiology.

  1999cited by this paper
• Phosphorylation of Myosin-Binding Subunit (Mbs) of Myosin Phosphatase by Rho-Kinase in Vivo

  1999cited by this paper
• Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus.

  1998cited by this paper
• High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

  1998cited by this paper
• Endothelial cells in physiology and in the pathophysiology of vascular disorders.

  1998cited by this paper
• Associations of Fibrinogen, Factor VII and PAI-1 with Baseline Findings among 10,500 Male Participants in a Prospective Study of Myocardial Infarction

  1998cited by this paper
• Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

  1998cited by this paper
• Troglitazone Improves Defects in Insulin Action , Insulin Secretion , Ovarian Steroidogenesis , and Fibrinolysis in Women with Polycystic Ovary Syndrome *

  1997cited by this paper
• Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells.

  1997cited by this paper
• Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide Synthase*

  1997cited by this paper
• Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.

  1997cited by this paper
• Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.

  1995cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Regulation of PAI-1 Gene Expression In Vivo

  1993cited by this paper
• Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications.

  1989cited by this paper
• Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter.

  1988cited by this paper

• Stress hyperglycemia ratio and machine learning model for prediction of all-cause mortality in critically ill patients with acute kidney injury: A cohort study from MIMIC-IV

  2026cites this paper
• Myosin Light Chain Phosphatase Plays an Important Role in Cardiac Fibrosis in a Model of Mineralocorticoid Receptor‐Associated Hypertension

  2024cites this paper
• Smoking cessation and vascular endothelial function

  2023cites this paper
• Effect of high-intensity interval training versus moderate-intensity continuous training on plasminogen activator inhibitor-1 in Type 2 diabetic women

  2022cites this paper
• An Exploratory Review of Potential Adjunct Therapies for the Treatment of Coronavirus Infections

  2021cites this paper
• Key milestones in the diabetes research: A comprehensive update

  2020cites this paper
• Diabetes and the Cardiovascular System

  2020cites this paper
• The blood brain barrier in cerebral ischemic injury – Disruption and repair

  2020cites this paper
• Milestones In Diabetes Research

  2020cites this paper
• Endothelial Dysfunction in Diabetic Retinopathy

  2020cites this paper
• Leukocyte Rho kinase activity and serum cystatin C affect cardiovascular events in acute coronary syndrome

  2020cites this paper
• Salidroside Restores an Anti-inflammatory Endothelial Phenotype by Selectively Inhibiting Endothelial Complement After Oxidative Stress

  2019cites this paper
• Elevated Platelet Galectin-3 and Rho-Associated Protein Kinase Activity Are Associated with Hemodialysis Arteriovenous Shunt Dysfunction among Subjects with Diabetes Mellitus

  2019cites this paper
• An Update on the Association of Protein Kinases with Cardiovascular Diseases.

  2019cites this paper
• ROCK-2-selective targeting and its therapeutic outcomes.

  2019cites this paper
• Inhibition of Rho-associated kinases suppresses cardiac myofibroblast function in engineered connective and heart muscle tissues.

  2019cites this paper
• Neuroprotection Mediated by Upregulation of Endothelial Nitric Oxide Synthase in Rho-Associated, Coiled-Coil-Containing Kinase 2 Deficient Mice.

  2018cites this paper
• Afadin Facilitates Vascular Endothelial Growth Factor–Induced Network Formation and Migration of Vascular Endothelial Cells by Inactivating Rho-Associated Kinase Through ArhGAP29

  2018cites this paper
• Kobe University Repository : Kernel タイトル Tit le The Cell Adhesion Molecule Necl-4 / CADM 4 Serves as a Novel Regulator for Contact Inhibit ion of Cell Movement and Proliferat ion 著者

  2018cites this paper
• Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy

  2018cites this paper
• N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes

  2017cites this paper
• Development of a plasminogen activator inhibitor (PAI-1) assay and comparison of plasma PAI-1 activity in hyperlipidemic/dyslipidemic dogs with either hyperadrenocorticism or diabetes mellitus, and healthy dogs.

  2017cites this paper
• Role of altered coagulation-fibrinolytic system in the pathophysiology of diabetic retinopathy.

  2017cites this paper
• Rho-kinase inhibitor treatment prevents pulmonary inflammation and coagulation in lipopolysaccharide-induced lung injury.

  2017cites this paper
• RhoA/Rho-Associated Kinase as Marker of Cardiovascular Health

  2016cites this paper
• Signaling pathways in diabetic nephropathy.

  2016cites this paper
• An overview of endothelial dysfunction in diabetes

  2016cites this paper
• TGR5 suppresses high glucose-induced upregulation of fibronectin and transforming growth factor-β1 in rat glomerular mesangial cells by inhibiting RhoA/ROCK signaling

  2016cites this paper
• Increased rho kinase activity in mononuclear cells of dialysis and stage 3-4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications.

  2016cites this paper
• Diabetes-associated dysregulated cytokines and cancer.

  2016cites this paper
• Emerging roles of the myocardin family of proteins in lipid and glucose metabolism

  2016cites this paper
• Effects and mechanism of moderate aerobic exercise on impaired fasting glucose improvement

  2015cites this paper
• The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation

  2015cites this paper
• RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy

  2015cites this paper
• Involvement of Rho-associated protein kinase (ROCK) and bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) in high glucose-increased alkaline phosphatase expression and activity in human coronary artery smooth muscle cells

  2015cites this paper
• Association of Rho/Rho-kinase gene polymorphisms and expressions with obesity-related metabolic syndrome.

  2015cites this paper
• Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications

  2015cites this paper
• The Isoform Spesific Roles of Rho-Kinases in Vascular Diseases

  2015cites this paper
• Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy.

  2014cites this paper
• Rho/Rho-Associated Coiled-Coil Forming Kinase Pathway as Therapeutic Targets for Statins in Atherosclerosis

  2014cites this paper
• Managing Cardiovascular Complications in Diabetes Normal Endothelial Cell Function

  2014cites this paper
• Fasudil hydrochloride hydrate, a Rho‐kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes

  2014cites this paper
• New angle of view on the role of rho/rho kinase pathway in human diseases.

  2014cites this paper
• Sulforaphane Inhibits TNF-α-Induced Adhesion Molecule Expression Through the Rho A/ROCK/NF-κB Signaling Pathway

  2014cites this paper
• The Vascular Endothelium in Diabetes

  2014cites this paper
• Fasudil inhibits epithelial-myofibroblast transdifferentiation of human renal tubular epithelial HK-2 cells induced by high glucose.

  2013cites this paper
• Increased leukocyte Rho-kinase activity in a population with acute coronary syndrome.

  2013cites this paper
• Glucose-independent persistence of PAI-1 gene expression and H3K4 tri-methylation in type 1 diabetic mouse endothelium: implication in metabolic memory.

  2013cites this paper
• VASCULAR BIOLOGY Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular in fl ammation

  2013cites this paper
• Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.

  2013cites this paper
• PKC-β Exacerbates in vitro Brain Barrier Damage in Hyperglycemic Settings via Regulation of RhoA/Rho-kinase/MLC2 Pathway

  2013cites this paper
• Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation.

  2013cites this paper
• Rho Kinases in Cardiovascular Physiology and Pathophysiology: The Effect of Fasudil

  2013cites this paper
• vascular inflammation Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute

  2013cites this paper
• Statins suppress glucose-induced plasminogen activator inhibitor-1 expression by regulating RhoA and nuclear factor-kB activities in cardiac microvascular endothelial cells

  2013cites this paper
• Pathophysiological role of RhoA/Rho-kinase under oxygen-glucose deprivation/reperfusion and hyperglycaemia

  2013cites this paper
• Hyperosmolar glucose induces vasoconstriction through Rho/Rho‐kinase pathway in the rat aorta

  2013cites this paper
• Metabolism of Methylarginines and Angiogenesis

  2013cites this paper
• VASCULAR BIOLOGY Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular in fl ammation

  2013cites this paper
• FHL2 prevents cardiac hypertrophy in mice with cardiac‐specific deletion of ROCK2

  2013cites this paper
• Angiogenesis and Vascularisation

  2013cites this paper
• High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels

  2012cites this paper
• Endothelial dysfunction and hypertension in aging

  2012cites this paper
• Rho kinase inhibitors: potential treatments for diabetes and diabetic complications.

  2012cites this paper
• Vasodilator effects of cromakalim and HA 1077 in diabetic rat aorta.

  2012cites this paper
• Rho kinase as a therapeutic target in cardiovascular disease.

  2011cites this paper
• Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes.

  2011cites this paper
• Metabolic Factors, Adipose Tissue, and Plasminogen Activator Inhibitor-1 Levels in Type 2 Diabetes: Findings From the Look AHEAD Study

  2011cites this paper
• Metabolic Factors , Adipose Tissue , and Plasminogen Activator Inhibitor-1 Levels in Type 2 Diabetes Findings From the Look AHEAD Study

  2011cites this paper
• Fasudil hydrochloride hydrate, a Rho‐kinase inhibitor, suppresses high glucose‐induced proliferation and collagen synthesis in rat cardiac fibroblasts

  2011cites this paper
• Role of Rho kinase isoforms in murine allergic airway responses

  2011cites this paper
• Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats

  2011cites this paper
• Rho-Associated Kinase Activity, Endothelial Function, and Cardiovascular Risk Factors

  2011cites this paper
• Long‐term diabetic complications may be ameliorated by targeting Rho kinase

  2011cites this paper
• Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.

  2011cites this paper
• ROCK Inhibition – A New Therapeutic Avenue in Kidney Protection

  2011cites this paper
• Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.

  2011cites this paper
• HYPERGLYCEMIA INDUCED CELL GROWTH AND GENE EXPRESSION VIA THE SERUM RESPONSE ELEMENT THROUGH RhoA AND Rho-KINASE IN VASCULAR SMOOTH MUSCLE CELLS

  2010influential citation
• Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease.

  2010cites this paper
• Fasudil hydrochloride induces osteoblastic differentiation of stromal cell lines, C3H10T1/2 and ST2, via bone morphogenetic protein-2 expression.

  2010cites this paper
• Hepatic expression profiling shows involvement of PKC epsilon, DGK eta, Tnfaip, and Rho kinase in type 2 diabetic nephropathy rats

  2010cites this paper
• RhoA/Rho kinase: a novel therapeutic target in diabetic complications.

  2010cites this paper
• RhoA/Rho-kinase and vascular diseases: what is the link?

  2010cites this paper
• Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokers

  2010cites this paper
• Revisited and Revised: Is RhoA Always a Villain in Cardiac Pathophysiology?

  2010cites this paper
• Regulation of the endothelial plasminogen activator system by fluvastatin

  2010cites this paper
• Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells.

  2010cites this paper
• The pericyte: cellular regulator of microvascular blood flow.

  2009cites this paper
• The role of the RhoA/rho-kinase pathway in pulmonary hypertension.

  2009cites this paper
• Statins inhibit Rho kinase activity in patients with atherosclerosis.

  2009cites this paper
• RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes.

  2009cites this paper
• Green tea polyphenols inhibit plasminogen activator inhibitor-1 expression and secretion in endothelial cells

  2009cites this paper
• Glycemic Index, Glycemic Load, and Thrombogenesis

  2009cites this paper
• Endothelial function and oxidative stress in cardiovascular diseases.

  2009cites this paper
• Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event.

  2009cites this paper
• Transient Insulin Resistance in Normal Subjects: Acute Hyperglycemia Inhibits Endothelial-Dependent Vasodilatation in Normal Subjects

  2008cites this paper
• TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.

  2008cites this paper
• Polymorphisms in Immune Response Genes in Infectious Diseases and Autoimmune Diseases

  2008cites this paper
• Integration of non-SMAD and SMAD signaling in TGF-β1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells

  2008cites this paper
• Development and post-pilot modification of a questionnaire for assessing dietary AGE intake in Australian children with and without type 1 diabetes mellitus

  2008cites this paper